PTK2 and neoplasm: In the context of gain‐of‐function Ret mutations, different studies have reached opposite conclusions regarding the ability of Fak to enhance or suppress Ret‐driven neoplasia (Panta et al, 2004; Plaza‐Menacho et al, 2011; Sandilands et al, 2012; Macagno et al, 2014).